TL;DR

Key Facts

What Are Pediatric Oral Infections?

Oral infections in pediatric patients encompass a wide spectrum of infectious diseases affecting the teeth, supporting periodontium, oral mucosa, salivary glands, and adjacent fascial spaces. They are among the most common reasons children present for emergency dental care and, in their more severe forms, represent a genuine medical emergency requiring prompt diagnosis and multidisciplinary management. Understanding pediatric oral infections requires integrating microbiology, clinical diagnosis, pharmacology, and surgical principles within the context of the developing dentition and the child’s systemic health status.

The most clinically significant infections in pediatric dentistry arise from the teeth themselves — specifically from untreated dental caries that penetrate the pulp and establish a route for microbial invasion of the periapical tissues. These odontogenic infections are by far the most common category in a dental practice. They range from a localized periapical abscess confined to a single tooth to a rapidly spreading cellulitis involving multiple fascial spaces of the head and neck. At their most severe, odontogenic infections can cause airway compromise, septicaemia, and death within 24–48 hours of apparent clinical stability — a reality that makes timely intervention and the ability to recognise warning signs of spreading infection essential competencies for every dentist treating children.

Alongside odontogenic infections, several non-odontogenic oral infections are important in pediatric practice. Primary herpetic gingivostomatitis, hand-foot-mouth disease, herpangina, and oral candidiasis are all common in children and frequently present to dental practices. Their recognition is important not just for clinical management, but because these conditions can be confused with odontogenic infection by clinicians who examine the oral cavity without an infectious disease differential diagnosis framework. A child with multiple oral ulcers from primary HSV infection does not require dental extractions; one with a spreading submandibular swelling from an abscessed primary molar requires immediate hospital referral.

Why It Matters (Clinical + Exam Context)

Pediatric oral infections are high-yield for dental board examinations because they integrate microbiology (organisms, antibiotic selection), clinical diagnosis (distinguishing abscess from cellulitis, odontogenic from viral), pharmacology (dosing by weight, penicillin allergy alternatives, IE prophylaxis regimens), and clinical decision-making (when to refer, when to hospitalise, when antibiotics are appropriate). Clinically, the stakes are high: under-treatment of a spreading odontogenic infection can be fatal; over-treatment with antibiotics for a viral infection is a contributor to antimicrobial resistance and causes unnecessary harm.

Clinical Relevance

• Antibiotics are adjuncts, not treatment: The definitive management of any odontogenic infection — periapical abscess, dentoalveolar abscess, or fascial space infection — is elimination of the source: pulpotomy, pulpectomy, extraction, or incision and drainage. Antibiotics reduce systemic bacterial load and help prevent local-to-regional spread, but they cannot penetrate the avascular centre of an abscess cavity in sufficient concentration to eradicate the infection. A child prescribed amoxicillin alone for an acute dental abscess — without source elimination — is being inadequately treated. Dentists who prescribe antibiotics as monotherapy for odontogenic infection are contributing to antimicrobial resistance without providing curative care.
• Fascial space infections can be fatal: The face and neck are divided by fascial planes into anatomical spaces that can become infected when an odontogenic or oropharyngeal infection spreads. Once infection traverses fascial barriers — and it can do so with alarming speed, particularly in children with compromised immunity or virulent organisms — it can track into the mediastinum (descending necrotising mediastinitis) or obstruct the airway (Ludwig’s angina). Any child with trismus, floor-of-mouth elevation, dysphagia, or respiratory difficulty in the context of dental infection requires immediate emergency referral.
• IE prophylaxis applies to a much narrower group than previously believed: Before 2007, the American Heart Association recommended antibiotic prophylaxis for a broad range of cardiac conditions including mitral valve prolapse and most congenital heart disease. The revised 2007 AHA guidelines — reaffirmed in 2021 — dramatically narrowed this to only four high-risk categories. Many clinicians and parents are still operating on pre-2007 recommendations; dentists must know the current criteria and communicate them clearly.
• Primary herpetic gingivostomatitis is frequently misdiagnosed: The combination of high fever, oral pain, and multiple intraoral ulcers in a young child is a classic presentation of primary HSV-1 gingivostomatitis. It is frequently misdiagnosed as: acute necrotising ulcerative gingivitis (ANUG — which is rare in healthy young children and involves the gingival margins specifically); aphthous stomatitis (typically milder, afebrile, affects non-keratinised mucosa, and does not affect the gingiva in the same pattern); herpangina (Coxsackie virus — ulcers limited to soft palate and tonsillar pillars, not gingiva); or erythema multiforme. Correct diagnosis determines whether the patient needs antiviral therapy, antibiotics, or neither.
• Viral oral infections are not treated with antibiotics: Antibiotic prescribing for viral oral infections (primary herpes, hand-foot-mouth disease, herpangina) is one of the most common prescribing errors in both medicine and dentistry. It provides no clinical benefit, exposes the patient to adverse effects (diarrhoea, hypersensitivity reactions, microbiome disruption), and contributes to community antimicrobial resistance. Understanding which infections require antiviral therapy, which require antifungal therapy, and which require only supportive care is fundamental to appropriate antimicrobial stewardship.

Odontogenic Infections

Odontogenic infections originate from the teeth — typically from a carious pulp that has become infected and from which bacteria spread to the periapical tissues, creating a periapical abscess. In the primary dentition, the thin furcation bone of primary molars means periapical infection frequently perforates the bone and presents as a parulis (gum boil) or buccal vestibular swelling. If untreated, the infection can spread through local tissues, producing cellulitis, and ultimately involve fascial spaces of the neck.

Bacteriology of Odontogenic Infections

Odontogenic infections are polymicrobial — they involve a mixture of aerobic, facultatively anaerobic, and obligately anaerobic organisms that reflect the complex flora of the oral cavity. The dominant organisms vary with the stage and location of infection:

• Streptococcus milleri group (S. anginosus, S. constellatus, S. intermedius): the principal aerobes in early-stage infections. S. intermedius in particular has a strong tendency to form abscesses. These are alpha- or non-haemolytic streptococci with a distinctive caramel/butterscotch odour on culture.
• Prevotella species (P. melaninogenica, P. intermedia): gram-negative anaerobes that are beta-lactamase producers — meaning they can inactivate penicillin and amoxicillin. Their presence in more established or recurrent infections is a reason to consider beta-lactam/beta-lactamase inhibitor combinations (amoxicillin-clavulanate).
• Fusobacterium nucleatum: gram-negative obligate anaerobe and key bridge organism in the transition from aerobic to anaerobic communities. Associated with spreading cellulitis and necrotising infections.
• Peptostreptococcus species: gram-positive obligate anaerobes, particularly prevalent in established deep-space infections.
• Porphyromonas gingivalis: gram-negative anaerobe, more prominent in periodontal-origin infections than pulpal-origin infections in children.

The practical implication of this microbiology is that empirical antibiotic selection for odontogenic infections must cover both aerobic streptococci and anaerobes — which is why penicillin (including amoxicillin) remains an effective first-line choice. However, beta-lactamase-producing anaerobes can render penicillins ineffective in established infections, making amoxicillin-clavulanate (Augmentin) a better choice for refractory or recurrent cases.

Abscess vs. Cellulitis

Distinguishing between a localized abscess and spreading cellulitis is one of the most clinically important determinations in managing a child with odontogenic infection — because their management differs substantially:

The physical finding of fluctuance — the sensation of fluid “give” on palpation of a swelling — indicates that pus has formed and that incision and drainage is the appropriate intervention. Attempting I&D on an indurated cellulitis (no pus yet) is not productive and causes unnecessary trauma. Conversely, failing to drain an abscess that is clearly fluctuant — and relying on antibiotics alone — is inadequate management.

Fascial Space Infections

The head and neck are traversed by fascial planes that create anatomical compartments (spaces). Odontogenic infections can spread along these planes, filling one or more spaces with pus and oedema. The clinical urgency depends on which spaces are involved and the proximity to critical structures:

• Buccal space: Most common fascial space infection in children, arising from maxillary or mandibular posterior teeth. Produces a swelling lateral to the buccinator muscle — visible as facial swelling below the zygoma and above the mandible. Generally manageable with I&D and antibiotics in an outpatient or day surgery setting.
• Canine (infraorbital) space: Infection from maxillary canines or incisors. Swelling obliterates the nasolabial fold and produces periorbital oedema. Risk of cavernous sinus thrombosis via the angular/facial vein — all maxillary anterior infections require careful monitoring.
• Masticator space: Involves masseter and/or medial pterygoid muscles. Hallmark: trismus (limited mouth opening). Arises from lower third molars or posterior mandibular teeth. Requires hospital admission and IV antibiotics.
• Submandibular space: Below the mylohyoid muscle. Swelling in the submandibular triangle. Key risk: spread to sublingual and contralateral submandibular space → Ludwig’s angina.
• Sublingual space: Above the mylohyoid, bilateral. Involvement produces elevation of the floor of the mouth — a critical sign of potential airway compromise.
• Lateral pharyngeal space: Adjacent to the pharynx. Produces dysphagia, neck swelling, and potential airway compromise. Risk of tracking to the carotid sheath or posterior mediastinum.
• Retropharyngeal space: Between the pharynx and prevertebral fascia. Infection here can track directly into the posterior mediastinum (descending necrotising mediastinitis) — a life-threatening emergency with very high mortality.

Antibiotic Management of Odontogenic Infections

Antibiotic selection for pediatric odontogenic infections is guided by the polymicrobial nature of the infection, the child’s allergy history, and the severity of the clinical presentation. All antibiotic doses in children are calculated by body weight:

Infective Endocarditis Prophylaxis

Infective endocarditis (IE) is a microbial infection of the heart’s endocardial surface — most commonly the cardiac valves. Dental procedures that breach the oral mucosa and cause bacteraemia have historically been considered a risk factor for IE in predisposed patients, and antibiotic prophylaxis has been recommended to reduce this risk. The 2007 AHA guidelines (reaffirmed and refined in 2021) substantially narrowed the indications compared to prior versions.

IE prophylaxis IS recommended for the following high-risk conditions:

• Prosthetic cardiac valve or prosthetic material used for cardiac valve repair
• Previous infective endocarditis
• Congenital heart disease (CHD): only unrepaired cyanotic CHD (including palliative shunts and conduits); completely repaired CHD with prosthetic material during the first 6 months post-procedure; repaired CHD with residual defects at or adjacent to the site of a prosthetic patch or prosthetic device
• Cardiac transplant recipients who develop cardiac valvulopathy

IE prophylaxis is NO LONGER recommended for: mitral valve prolapse (with or without regurgitation), rheumatic heart disease, bicuspid aortic valve, calcified aortic stenosis, most congenital heart conditions repaired without residual defects, ventricular septal defects without prosthetic material, atrial septal defects, and patent ductus arteriosus.

Dental procedures requiring prophylaxis (in the above high-risk patients): any manipulation of gingival tissue or the periapical region of teeth, or perforation of the oral mucosa. This includes extractions, periodontal procedures, scaling, prophylaxis that involves gingival manipulation, implant placement, and replantation of avulsed teeth. It does NOT include routine examination, radiographs, orthodontic appliance placement (on intact mucosa), or shedding of primary teeth.

Prophylaxis regimen:

• Amoxicillin 50 mg/kg PO (maximum 2 g) 30–60 minutes before the procedure
• If unable to take oral medication: ampicillin 50 mg/kg IM or IV (max 2 g) within 30 minutes before the procedure
• Penicillin/ampicillin allergy: clindamycin 20 mg/kg PO or IV (max 600 mg); or azithromycin/clarithromycin 15 mg/kg PO (max 500 mg)

Viral and Fungal Oral Infections in Children

Several important oral infections in children are caused by viruses or fungi rather than bacteria, and their recognition is critical because their management differs fundamentally from odontogenic bacterial infections. The common thread is that antibiotics are inappropriate — not just ineffective, but potentially harmful by disrupting the normal oral flora.

Primary Herpetic Gingivostomatitis

Primary herpetic gingivostomatitis is the clinical manifestation of the first infection with herpes simplex virus type 1 (HSV-1). It occurs most commonly in children aged 6 months to 5 years, following loss of maternal antibody protection. After primary infection, HSV-1 establishes latency in the trigeminal ganglion and may later reactivate as recurrent herpes labialis (cold sores on the vermilion border).

Clinical presentation:

• Prodrome (1–2 days): Fever (38–40°C), irritability, anorexia, lymphadenopathy (submandibular nodes), malaise. Young children often refuse to eat or drink.
• Acute phase (3–5 days): Multiple small vesicles that rapidly rupture to form painful yellow-grey ulcers with erythematous haloes. Critically, these ulcers affect both attached (keratinised) and non-attached (non-keratinised) mucosa — the gingiva, tongue, hard and soft palate, buccal mucosa, and lips. Acute erythema and oedema of the gingiva is a hallmark finding. The entire oral cavity may be involved.
• Resolution: Ulcers heal without scarring over 7–14 days. Oral feeding resumes as pain diminishes.

Differential diagnosis — distinguishing features:

• Aphthous stomatitis: Typically afebrile, non-keratinised mucosa only (buccal mucosa, floor of mouth, soft palate, lateral tongue), not the gingiva. Usually 1–5 ulcers, not dozens.
• Herpangina (Coxsackie A): Ulcers limited to posterior oropharynx — soft palate, anterior tonsillar pillars, uvula. No anterior oral involvement. No gingival involvement.
• ANUG (Vincent’s infection): Punched-out ulcers at gingival interdental papillae specifically. Distinctive foetor oris. Pseudomembrane formation. Rare in healthy children under 10 years.
• Hand-foot-mouth disease: Oral ulcers plus vesicular rash on palms, soles, and buttocks. Systemic mild illness.
• Erythema multiforme: Target lesions on skin; oral ulcers with haemorrhagic crusting of lips. Often triggered by HSV itself or medications.

Management:

• Supportive: adequate fluid intake (risk of dehydration in very young children), soft diet, analgesics (paracetamol or ibuprofen by weight).
• Antiviral: acyclovir (15 mg/kg/dose five times daily for 7 days, max 200 mg/dose) significantly reduces fever duration, pain, and viral shedding — but only if started within 72 hours of symptom onset. After 72 hours, antiviral therapy provides minimal benefit.
• Hospital admission for IV acyclovir if unable to maintain oral hydration, immunocompromised, or eczema herpeticum (disseminated cutaneous HSV in patients with atopic eczema).
• Antibiotics: NOT indicated.
• Infection control: HSV-1 is shed in oral secretions during the active phase. Child should be kept away from other young children, neonates, and immunocompromised individuals. Clinical staff should wear gloves and avoid direct contact with herpetic lesions. Standard PPE prevents transmission in the dental setting.

Hand-Foot-Mouth Disease and Herpangina

Both conditions are caused by enteroviruses — most commonly Coxsackie virus A16 (HFMD) and Coxsackie A viruses (herpangina). They present with oral lesions that can superficially resemble primary herpes or aphthous stomatitis.

Hand-foot-mouth disease (HFMD): Typically affects children under 5 years. After a 3–5 day incubation, the child develops mild fever, malaise, and within 1–2 days: multiple small vesicles or ulcers on the buccal mucosa, tongue, and palate, accompanied by a vesicular rash on the palms of the hands, soles of the feet, and buttocks. The rash is diagnostic — oral-only presentations require differentiation from primary herpes. Enterovirus 71 (EV71) is a more virulent strain associated with outbreaks in Asia and is rarely associated with neurological complications (brainstem encephalitis, acute flaccid paralysis). Management is supportive only; no antiviral therapy is effective. The condition is self-limiting over 7–10 days.

Herpangina: Coxsackie A viruses (A1–A6, A8, A10, A22) cause herpangina — characterized by sudden onset high fever, sore throat, and 2–6 grey-white vesicles or ulcers that appear exclusively on the soft palate, anterior tonsillar pillars, and uvula. The anterior oral cavity is spared — distinguishing it from primary herpes (which involves the anterior mucosa prominently). Resolution in 3–5 days. Management is supportive.

Oral Candidiasis (Thrush)

Oral candidiasis is a fungal infection caused by Candida albicans — a commensal organism of the oral flora that becomes pathogenic when host defences are compromised or the oral environment changes. In children, the most common predisposing factors are:

• Recent or ongoing antibiotic therapy (disrupts bacterial flora, allowing Candida overgrowth)
• Inhaled corticosteroids (asthma inhalers) — candidiasis develops in up to 10% of users if spacers are not used and the mouth is not rinsed after inhalation
• Immunosuppression (HIV, leukaemia, immunosuppressive drug therapy, chemotherapy)
• Neonates — especially after passage through an infected birth canal (vertical transmission) or prolonged NICU admission with antibiotics and parenteral nutrition
• Denture-wearing (older children with prostheses for hypodontia — candidiasis under the denture base)

Clinical types in children:

• Pseudomembranous candidiasis (thrush): The most common type. Creamy-white or yellow-white plaques on the buccal mucosa, tongue, palate, and oropharynx. The plaques wipe off with a gauze pad, leaving an erythematous, sometimes bleeding base. This wiping-off distinguishes candidiasis from leukoplakia (which cannot be wiped off) and milk curd residue (which does wipe off but without an erythematous base).
• Erythematous (atrophic) candidiasis: Red, painful patches on the hard palate or dorsal tongue, often associated with inhaled corticosteroid use. The tongue may appear smooth and depapillated.
• Angular cheilitis: Fissuring, erythema, and scaling at the corners of the mouth — can be candidal, bacterial, or mixed. Associated with drooling, thumb-sucking, and nutritional deficiency in children.

Treatment:

• Nystatin oral suspension (100,000 units/mL): 1–2 mL applied with a dropper or swab to the affected area four times daily, after feeds, for 14 days. The suspension must contact the affected mucosa — simply swallowing it is inadequate. For infants, a swab applied after feeds is more effective than a dropper.
• Miconazole oral gel (2%): Applied to affected mucosa four times daily. Preferred by some guidelines because it has better adherence to mucosa. Avoid in children under 4 months (choking risk with gel formulation).
• Fluconazole: Systemic antifungal reserved for immunocompromised patients, recurrent or refractory cases, or oesophageal candidiasis. Dose: 3–6 mg/kg/day PO. Single-dose fluconazole is often curative in older children with straightforward pseudomembranous candidiasis.
• Address the predisposing factor: advise inhaler spacer use and post-inhalation mouth rinsing; review indication for antibiotics; refer for immunological investigation if recurrent infections suggest immune deficiency.

Pericoronitis in Adolescents

Pericoronitis is infection of the soft tissue (operculum) overlying a partially erupted tooth — almost exclusively the mandibular third molar in adolescents and young adults. The operculum traps food debris and creates an anaerobic microenvironment beneath it, promoting polymicrobial infection. Clinical presentation: pain, swelling, and erythema of the operculum overlying the erupting wisdom tooth; trismus if the masticator space is involved; in severe cases, extension to the pterygomandibular or lateral pharyngeal space.

Management: Irrigation of the pericoronal space with saline or chlorhexidine (0.12%) using a curved irrigation tip is the primary treatment. If the opposing upper third molar is traumatising the operculum, its extraction may dramatically reduce recurrence. Antibiotics (amoxicillin 50 mg/kg/day TID, or metronidazole 30 mg/kg/day TID if predominantly anaerobic) are indicated only if systemic signs are present (fever, lymphadenopathy, trismus) or if infection is spreading. Definitive management is extraction of the offending lower third molar once the acute episode resolves — pericoronitis recurs in the majority of conservatively managed cases. Operculectomy (excision of the operculum) is occasionally appropriate if the tooth is expected to fully erupt and the space infection is recurrent.

Clinical Considerations

• Recognise the six warning signs of spreading odontogenic infection and act immediately: Trismus (inability to open the mouth fully due to masticator space involvement), dysphagia (difficulty swallowing — lateral pharyngeal or submandibular space), drooling (inability to swallow saliva — floor-of-mouth elevation), stridor or hoarse voice (laryngeal oedema), floor-of-mouth elevation, and progressive facial swelling despite antibiotics. Any one of these in a child with dental infection warrants immediate emergency department referral. Do not prescribe additional antibiotics and monitor from the office — these children need airway security, IV antibiotics, and surgical drainage under general anaesthesia.
• The primary tooth abscess vs. permanent tooth: management philosophy differs: For primary teeth with periapical pathology, the treatment decision must weigh the value of space maintenance against the risk of further spread and damage to the successor permanent tooth. A primary molar with a draining sinus and a cooperative patient is often best managed with pulpectomy and stainless steel crown, preserving space and resolving infection. However, a primary tooth with significant furcation bone loss, a non-restorable crown, or involvement of the permanent tooth crypt (evidenced radiographically) should be extracted. Unlike permanent teeth, extracting a primary tooth for infection is not a sign of clinical failure — it is sometimes the correct and safest choice.
• Culture and sensitivity testing for severe infections: For any odontogenic infection requiring hospital admission, IV antibiotics, or surgical drainage in an operating room, a pus specimen should be collected for aerobic and anaerobic culture and sensitivity testing before antibiotics are started (or at the time of I&D). This allows antibiotic therapy to be rationalised once culture results return — particularly important in immunocompromised children, those with a history of treatment failure, and cases involving unusual or resistant organisms.
• Antibiotic prescribing: duration matters. For uncomplicated odontogenic infections in children, antibiotic courses should be 5–7 days — no longer. There is no evidence that longer courses are more effective, and they increase the risk of adverse effects (particularly antibiotic-associated diarrhoea and Clostridioides difficile infection) and resistance selection. The now-outdated practice of prescribing 10-day courses for dental infections is not supported by current evidence. If the infection is not responding after 3–4 days of appropriate antibiotics with source control, review the diagnosis — not the antibiotic duration.
• Immunocompromised children require special vigilance: Children on chemotherapy, systemic corticosteroids, or with congenital immune deficiencies may not mount the usual inflammatory response to odontogenic infection. They may present with atypical signs — minimal swelling but severe systemic illness — and can deteriorate far more rapidly than healthy children. Oral mucositis from chemotherapy creates a portal of entry for systemic infection. These patients require collaboration with their medical team before and after dental procedures, and antibiotic thresholds for prophylaxis and treatment should be lowered. Absolute neutrophil count (ANC) below 500/µL is a threshold below which elective dental procedures are deferred and any infection treated aggressively.
• Parent education on preventing recurrent odontogenic infections: An acute dental abscess is not a random event — it is the end-stage of a preventable disease (caries). After emergency treatment, every child presenting with a dental abscess requires a comprehensive prevention counselling session: dietary review (frequency of sugar exposure), oral hygiene instruction tailored to the child’s age, fluoride varnish application, assessment for pit-and-fissure sealants on erupted permanent molars, and scheduling of a comprehensive examination to identify all other teeth at risk. Treating the abscess tooth without addressing the underlying cariogenic risk means the same child will return with another dental emergency.

Common Mistakes & Misconceptions

• Misconception: “Antibiotics alone are sufficient to treat a dental abscess in a child.”
  Correction: Antibiotics are adjuncts to — never a replacement for — surgical management of odontogenic infection. An abscess is a walled-off collection of pus with no blood supply at its centre; antibiotics cannot achieve bactericidal concentrations within the abscess cavity. The infected pulp or pus collection must be physically eliminated (pulpotomy, pulpectomy, extraction, or I&D). Prescribing antibiotics without addressing the source may temporarily reduce systemic signs while the local infection continues to develop, increasing the risk of fascial space spread.
• Misconception: “Primary herpetic gingivostomatitis should be treated with antibiotics because it causes severe gingival inflammation.”
  Correction: Primary herpetic gingivostomatitis is a viral infection — antibiotics have no effect on HSV-1 replication and should not be prescribed. Secondary bacterial superinfection is rare in immunocompetent children. The appropriate management is antiviral therapy (acyclovir) within 72 hours of onset, plus supportive care. The misidentification of viral gingivostomatitis as a bacterial infection — and treatment with amoxicillin — is one of the most common prescribing errors encountered in pediatric dental emergency settings.
• Misconception: “All children with congenital heart disease need antibiotic prophylaxis before dental procedures.”
  Correction: The 2007 AHA guidelines (reaffirmed 2021) restrict IE prophylaxis to four specific high-risk categories: prosthetic cardiac valves, previous IE, certain unrepaired or incompletely repaired congenital heart lesions, and cardiac transplant with valvulopathy. The majority of congenital heart conditions — including repaired VSDs, repaired ASDs, mild pulmonary stenosis, and mitral valve prolapse — no longer require prophylaxis. Providing unnecessary prophylaxis exposes children to antibiotic adverse effects without benefit; it also represents a failure to communicate current evidence to parents who may have been given outdated advice by cardiologists or paediatricians.
• Misconception: “A fluctuant swelling should always be incised and drained in the dental office.”
  Correction: While I&D is the correct treatment for a localized fluctuant abscess, not every swelling with apparent fluctuance should be drained in the office. Swellings involving deep fascial spaces (masticator, submandibular, sublingual, parapharyngeal), those in proximity to major vessels, those in an uncooperative child requiring general anaesthesia, or those associated with trismus or airway compromise should be managed in a hospital setting by an oral and maxillofacial surgeon. Attempting to drain a deep space infection in the office risks neurovascular injury, incomplete drainage, and inadequate airway monitoring. A sound clinical principle: if you cannot see the floor of the abscess clearly, don’t drain it in the chair.
• Misconception: “Oral candidiasis in a child is always caused by poor oral hygiene.”
  Correction: Oral candidiasis in children typically arises from a change in the host environment or defence mechanism — not poor hygiene. The most common triggers are recent antibiotic use, inhaled corticosteroid use without adequate mouth rinsing, neonatal infection, or immunosuppression. In a well-nourished immunocompetent child over 12 months with no recent antibiotic use, recurrent oral candidiasis should prompt evaluation for immune deficiency (IgA deficiency, chronic mucocutaneous candidiasis, HIV). Treating the fungal infection without addressing the underlying predisposing factor leads to inevitable recurrence.

Related Topics

Pediatric oral infections connect microbiology, pharmacology, systemic medicine, and clinical pediatric dental practice across the full scope of the specialty.

References & Sources

This article draws on AAPD clinical guidelines, AHA endocarditis prophylaxis guidelines, and established pediatric oral medicine and microbiology references.

1. Wilson WR, Gewitz M, Lockhart PB, et al. (2021). Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement from the American Heart Association. Circulation, 143(20):e963–e978.
2. American Academy of Pediatric Dentistry (2022). Antibiotic Prophylaxis for Dental Patients at Risk for Infection. The Reference Manual of Pediatric Dentistry. AAPD.
3. American Academy of Pediatric Dentistry (2022). Use of Antibiotic Therapy for Pediatric Dental Patients. The Reference Manual of Pediatric Dentistry. AAPD.
4. Nowak AJ, Christensen JR, Mabry TR, Townsend JA, Wells MH (2019). Pediatric Dentistry: Infancy through Adolescence, 6th ed. Elsevier. [Chapters on Oral Medicine and Infections]
5. Sapp JP, Eversole LR, Wysocki GP (2004). Contemporary Oral and Maxillofacial Pathology, 2nd ed. Mosby. [Viral and fungal oral infections chapter]
6. Flynn TR (2011). What are the antibiotics of choice for odontogenic infections, and how long should the treatment course last? Oral and Maxillofacial Surgery Clinics of North America, 23(4):519–536.
7. Cernik C, Gallina K, Brodell RT (2008). The treatment of herpes simplex infections: an evidence-based review. Archives of Internal Medicine, 168(11):1137–1144.
8. Lalla RV, Patton LL, Dongari-Bagtzoglou A (2013). Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies. Journal of the California Dental Association, 41(4):263–268.

Summary

Pediatric oral infections represent a clinically diverse group of conditions requiring differential diagnosis, accurate aetiological identification, and evidence-based management. Odontogenic infections — arising from infected dental pulps and progressing through periapical, dentoalveolar, and potentially fascial space involvement — are by far the most clinically significant category. Their management is founded on source elimination (pulp therapy or extraction) with antibiotics as adjuncts, never as monotherapy. The ability to distinguish a localised fluctuant abscess from spreading cellulitis, to recognise the early signs of fascial space infection, and to know when to refer to hospital are core competencies that every dentist treating children must possess. Non-odontogenic viral and fungal infections — primary herpes, hand-foot-mouth disease, herpangina, and oral candidiasis — are common in pediatric practice and are frequently misidentified. Their recognition prevents inappropriate antibiotic prescribing and ensures timely antiviral or antifungal therapy where indicated. Infective endocarditis prophylaxis, once broadly applied, is now restricted to a narrow high-risk cardiac group — understanding the current AHA criteria is essential for both clinical safety and appropriate antibiotic stewardship in the pediatric dental setting.

About the Author

Dr. Andries Smith

Founder, Dental Panda

Dr. Andries Smith founded Dental Panda in 2020. As an immigrant to the United States, he had to take the INBDE exam, even though he was practicing dentistry for over 10 years. This revealed an opportunity. Andries noticed that INBDE prep course companies were putting profit over students. With his expertise and experience in dentistry, he created free dental wiki resources for students and the general public to have access to.